260 related articles for article (PubMed ID: 37212258)
1. Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects.
Sammartino JC; Cassaniti I; Ferrari A; Piralla A; Bergami F; Arena FA; Paolucci S; Rovida F; Lilleri D; Percivalle E; Baldanti F
J Med Virol; 2023 May; 95(5):e28778. PubMed ID: 37212258
[TBL] [Abstract][Full Text] [Related]
2. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
[TBL] [Abstract][Full Text] [Related]
3. Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.
Otter AD; Jones S; Hicks B; Bailey D; Callaby H; Houlihan C; Rampling T; Gordon NC; Selman H; Satheshkumar PS; Townsend M; Mehta R; Pond M; Jones R; Wright D; Oeser C; Tonge S; Linley E; Hemingway G; Coleman T; Millward S; Lloyd A; Damon I; Brooks T; Vipond R; Rowe C; Hallis B
Nat Commun; 2023 Sep; 14(1):5948. PubMed ID: 37741831
[TBL] [Abstract][Full Text] [Related]
4. Monkeypox: A New Threat?
Kmiec D; Kirchhoff F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887214
[TBL] [Abstract][Full Text] [Related]
5. Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.
Hubert M; Guivel-Benhassine F; Bruel T; Porrot F; Planas D; Vanhomwegen J; Wiedemann A; Burrel S; Marot S; Palich R; Monsel G; Diombera H; Gallien S; Lopez-Zaragoza JL; Vindrios W; Taieb F; Fernandes-Pellerin S; Delhaye M; Laude H; Arowas L; Ungeheuer MN; Hocqueloux L; Pourcher V; Prazuck T; Marcelin AG; Lelièvre JD; Batéjat C; Lévy Y; Manuguerra JC; Schwartz O
Cell Host Microbe; 2023 Jun; 31(6):937-948.e4. PubMed ID: 37196656
[TBL] [Abstract][Full Text] [Related]
6. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals.
Zaeck LM; Lamers MM; Verstrepen BE; Bestebroer TM; van Royen ME; Götz H; Shamier MC; van Leeuwen LPM; Schmitz KS; Alblas K; van Efferen S; Bogers S; Scherbeijn S; Rimmelzwaan GF; van Gorp ECM; Koopmans MPG; Haagmans BL; GeurtsvanKessel CH; de Vries RD
Nat Med; 2023 Jan; 29(1):270-278. PubMed ID: 36257333
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history.
Xia A; Wang X; He J; Wu W; Jiang W; Xue S; Zhang Q; Gao Y; Han Y; Li Y; Peng X; Xie M; Mayer CT; Liu J; Hua C; Sha Y; Xu W; Huang J; Ying T; Jiang S; Xie Y; Cai Q; Lu L; Silva IT; Yuan Z; Zhang Y; Wang Q
BMC Biol; 2023 Oct; 21(1):205. PubMed ID: 37784185
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of monkeypox- and vaccinia-virus neutralizing antibodies before and after smallpox vaccination: A sero-epidemiological study.
Marchi S; Piccini G; Cantaloni P; Guerrini N; Zannella R; Coluccio R; Benincasa L; Solfanelli N; Remarque EJ; Viviani S; Kistner O; Temperton N; Montomoli E; Manenti A; Trombetta CM
J Med Virol; 2024 Jun; 96(6):e29728. PubMed ID: 38860589
[TBL] [Abstract][Full Text] [Related]
9. Monkeypox Goes North: Ongoing Worldwide Monkeypox Infections in Humans.
Schnierle BS
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146681
[TBL] [Abstract][Full Text] [Related]
10. State-of-the-art on monkeypox virus: an emerging zoonotic disease.
Shafaati M; Zandi M
Infection; 2022 Dec; 50(6):1425-1430. PubMed ID: 36192607
[TBL] [Abstract][Full Text] [Related]
11. Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II.
Criscuolo E; Giuliani B; Ferrarese R; Ferrari D; Locatelli M; Clementi M; Mancini N; Clementi N
J Med Virol; 2023 Mar; 95(3):e28643. PubMed ID: 36890648
[TBL] [Abstract][Full Text] [Related]
12. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
[TBL] [Abstract][Full Text] [Related]
13. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.
Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ
Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141
[TBL] [Abstract][Full Text] [Related]
14. Monkeypox virus: a re-emergent threat to humans.
Gong Q; Wang C; Chuai X; Chiu S
Virol Sin; 2022 Aug; 37(4):477-482. PubMed ID: 35820590
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination.
Matusali G; Petruccioli E; Cimini E; Colavita F; Bettini A; Tartaglia E; Sbarra S; Meschi S; Lapa D; Francalancia M; Bordi L; Mazzotta V; Coen S; Mizzoni K; Beccacece A; Nicastri E; Pierelli L; Antinori A; Girardi E; Vaia F; Sette A; Grifoni A; Goletti D; Puro V; Maggi F
Vaccines (Basel); 2023 Sep; 11(10):. PubMed ID: 37896943
[TBL] [Abstract][Full Text] [Related]
16. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population.
Feng Y; Zhang Y; Liu S; Guo M; Huang H; Guo C; Wang W; Zhang W; Tang H; Wan Y
BMC Med; 2023 May; 21(1):183. PubMed ID: 37189197
[TBL] [Abstract][Full Text] [Related]
17. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans.
Grifoni A; Zhang Y; Tarke A; Sidney J; Rubiro P; Reina-Campos M; Filaci G; Dan JM; Scheuermann RH; Sette A
Cell Host Microbe; 2022 Dec; 30(12):1662-1670.e4. PubMed ID: 36463861
[TBL] [Abstract][Full Text] [Related]
18. Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV-1 from Guangzhou, China.
Dai J; Li F; Yang Y; Tang X; Li L; Yu H
J Med Virol; 2023 May; 95(5):e28763. PubMed ID: 37212313
[TBL] [Abstract][Full Text] [Related]
19. Strategy of developing nucleic acid-based universal monkeypox vaccine candidates.
Papukashvili D; Rcheulishvili N; Liu C; Wang X; He Y; Wang PG
Front Immunol; 2022; 13():1050309. PubMed ID: 36389680
[TBL] [Abstract][Full Text] [Related]
20. Monkeypox virus: The changing facets of a zoonotic pathogen.
Forni D; Cagliani R; Molteni C; Clerici M; Sironi M
Infect Genet Evol; 2022 Nov; 105():105372. PubMed ID: 36202208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
